Renown Pharmaceuticals Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Renown Pharmaceuticals Private Limited Pharmaceutical Export Portfolio Dataset — 3 Products, $1.8M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Renown Pharmaceuticals Private Limited — Pharmaceutical Exporter Profile (2026) | 3 Products, $1.8M Trade | TransData Nexus

Renown Pharmaceuticals Private Limited

Indian Pharmaceutical Exporter · Nutritional Supplements Specialist · $1.8M Total Trade · DGFT Verified

Renown Pharmaceuticals Private Limited is an Indian pharmaceutical exporter with a total trade value of $1.8M across 3 products in 2 therapeutic categories. Based on 103 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Vitamin ($1.6M), Natural ($150.0K), Omega ($104.9K).

Renown Pharmaceuticals Private Limited — Export Portfolio & Destination Treemap

Renown Pharmaceuticals Private Limited pharmaceutical export portfolio — 3 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Renown Pharmaceuticals Private Limited? — Company Overview & Market Position

Renown Pharmaceuticals Private Limited, established on September 5, 2005, is a private limited company headquartered in Vadodara, Gujarat, India. The company is registered under the Corporate Identification Number (CIN) U24230GJ2005PTC046714. It operates in the pharmaceutical sector, focusing on the manufacture of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The authorized share capital stands at ₹21.50 crore, with a paid-up capital of ₹16.50 crore. As of December 18, 2025, Renown Pharmaceuticals employed approximately 71 professionals.

What Does Renown Pharmaceuticals Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Vitamin$1.6M 2Natural$150.0K 3

Product Portfolio — Top 3 by Export Value

Renown Pharmaceuticals Private Limited exports 3 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Vitamin	Nutritional Supplements	$1.6M	93	1.1%	14
2	Natural	Ayurvedic & Herbal Products	$150.0K	3	0.6%	14
3	Omega	Nutritional Supplements	$104.9K	7	0.6%	11

Renown Pharmaceuticals Private Limited exports 3 pharmaceutical products across 2 therapeutic categories with a total export value of $1.8M. The top category is Nutritional Supplements (91.8% of portfolio), followed by Ayurvedic & Herbal Products (8.2%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Renown Pharmaceuticals Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Renown Pharmaceuticals operates a state-of-the-art manufacturing facility in Vadodara, Gujarat. The plant is equipped with three encapsulation lines and has provisions for five additional lines, indicating a capacity to scale operations as needed. The facility adheres to international standards, including WHO-GMP and ISO certifications, ensuring the production of high-quality pharmaceutical products.

3Key Leadership

The leadership team at Renown Pharmaceuticals comprises:

Ramesh Kumar Jatia: Managing Director, appointed on December 31, 2009.

Smita Jatia Rameshkumar: Director, appointed on September 5, 2005.

Atishay Jatia Ramesh: Director, appointed on September 28, 2007.

Satish Bangera Duggappa: Director, appointed on December 31, 2009.

Additionally, Scany Prabhudas Parmar serves as the Company Secretary, appointed on October 1, 2022.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Renown Pharmaceuticals Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Renown Pharmaceuticals has made significant strides in regulated markets, particularly in the United States, European Union, United Kingdom, and Australia. The company's manufacturing facility is designed to meet the stringent requirements of regulatory bodies such as the MHRA (UK), TGA (Australia), and WHO-GMP, facilitating market access in these regions. Renown Pharmaceuticals has expressed intentions to enter the US OTC and TGA segments in the near future, indicating a proactive approach to expanding its global footprint.

2Emerging Markets

Renown Pharmaceuticals has also focused on penetrating emerging markets in Africa, Latin America, and Southeast Asia. The company's adherence to WHO-GMP standards enhances its credibility and facilitates access to these markets. By ensuring compliance with international quality standards, Renown Pharmaceuticals positions itself as a reliable supplier in these regions.

3Geographic Strategy

Renown Pharmaceuticals demonstrates a diversified geographic strategy by targeting both regulated and emerging markets. This approach mitigates concentration risk and leverages growth opportunities across different regions. The company's commitment to adhering to international quality standards, such as WHO-GMP and ISO certifications, supports its strategic direction and enhances its competitive position globally.

Renown Pharmaceuticals Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

As of March 28, 2026, specific details regarding Renown Pharmaceuticals' FDA facility registrations, approved ANDAs, DMF filings, and inspection history are not publicly available. The company's focus on WHO-GMP and ISO certifications suggests a commitment to meeting international quality standards, which is a prerequisite for FDA approvals. However, without explicit FDA approvals or registrations, the company's products may face challenges entering the U.S. market.

2WHO & EU GMP

Renown Pharmaceuticals' manufacturing facility is designed to meet WHO-GMP and EU GMP standards, ensuring the production of high-quality pharmaceutical products. These certifications are crucial for market access in various international markets, including the European Union and other regions that recognize WHO-GMP standards. The company's adherence to these standards underscores its commitment to quality and regulatory compliance.

3CDSCO & Indian Regulatory

Renown Pharmaceuticals Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Renown Pharmaceuticals operates in a competitive landscape with several key players in the pharmaceutical manufacturing sector. While specific competitors are not identified in the available data, the company's focus on high-quality manufacturing, adherence to international standards, and strategic geographic diversification position it favorably in the market. Renown Pharmaceuticals' commitment to quality and regulatory compliance enhances its competitiveness in both regulated and emerging markets.

2Key Differentiators

Renown Pharmaceuticals' key differentiators include its state-of-the-art manufacturing facility designed to meet WHO-GMP and ISO standards, a diversified product portfolio encompassing nutritional supplements and Ayurvedic & herbal products, and a strategic focus on both regulated and emerging markets. These factors collectively enhance the company's competitive advantage and market positioning.

3Strategic Position

Renown Pharmaceuticals is strategically positioned as a contract manufacturer specializing in soft gelatin capsules, catering to both pharmaceutical and nutraceutical sectors. The company's adherence to international quality standards, such as WHO-GMP and ISO certifications, supports its strategic direction and enhances its appeal to global clients. Looking ahead, Renown Pharmaceuticals aims to expand its presence in regulated markets, including the U.S. OTC and TGA segments, while continuing to serve emerging markets.

Buyer Due Diligence Brief — Evaluating Renown Pharmaceuticals Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Renown Pharmaceuticals has demonstrated a consistent track record in pharmaceutical manufacturing, with a total export value of $1.8 million USD and 103 shipments across 2 therapeutic categories. The company's portfolio concentration is notable, with its top 5 products accounting for 100% of exports. This focus on a select range of products indicates a strategic approach to market positioning and resource allocation. The company's adherence to international quality standards, such as WHO-GMP and ISO certifications, further underscores its reliability as a supplier.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

WHO-GMP Certification: Indicates adherence to World Health Organization Good Manufacturing Practices. Verification can be done through the WHO website or by contacting the company directly.

EU GMP Certification: Demonstrates compliance with European Union Good Manufacturing Practices. Verification can be conducted through the European Medicines Agency (EMA) or by reaching out to the company.

Frequently Asked Questions — Renown Pharmaceuticals Private Limited

How many pharmaceutical products does Renown Pharmaceuticals Private Limited export from India?

Renown Pharmaceuticals Private Limited exports 3 pharmaceutical products across 2 therapeutic categories. The top exports are Vitamin ($1.6M), Natural ($150.0K), Omega ($104.9K). Total export value is $1.8M.

What is Renown Pharmaceuticals Private Limited's total pharmaceutical export value?

Renown Pharmaceuticals Private Limited's total pharmaceutical export value is $1.8M, based on 103 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Renown Pharmaceuticals Private Limited cover?

Renown Pharmaceuticals Private Limited exports across 2 therapeutic categories. The largest are Nutritional Supplements (91.8%, 2 products), Ayurvedic & Herbal Products (8.2%, 1 products).

Get Full Renown Pharmaceuticals Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.